These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 30791230)
21. Efficiency of ultrafiltration/diafiltration in removing organic and elemental process equipment related leachables from biological therapeutics. Sun B; Hadidi M; Santiago Nuñez J; Song B; Tumambac GE; Wong K; Kalinowski G; Hathcock JJ Biotechnol Prog; 2024; 40(1):e3400. PubMed ID: 37964726 [TBL] [Abstract][Full Text] [Related]
22. Single pass diafiltration integrated into a fully continuous mAb purification process. Rucker-Pezzini J; Arnold L; Hill-Byrne K; Sharp T; Avazhanskiy M; Forespring C Biotechnol Bioeng; 2018 Aug; 115(8):1949-1957. PubMed ID: 29663323 [TBL] [Abstract][Full Text] [Related]
23. Strategies for high-concentration drug substance manufacturing to facilitate subcutaneous administration: A review. Holstein M; Hung J; Feroz H; Ranjan S; Du C; Ghose S; Li ZJ Biotechnol Bioeng; 2020 Nov; 117(11):3591-3606. PubMed ID: 32687221 [TBL] [Abstract][Full Text] [Related]
24. Multi-criteria manufacturability indices for ranking high-concentration monoclonal antibody formulations. Yang Y; Velayudhan A; Thornhill NF; Farid SS Biotechnol Bioeng; 2017 Sep; 114(9):2043-2056. PubMed ID: 28464235 [TBL] [Abstract][Full Text] [Related]
25. Charge heterogeneity profiling of monoclonal antibodies using low ionic strength ion-exchange chromatography and well-controlled pH gradients on monolithic columns. Talebi M; Nordborg A; Gaspar A; Lacher NA; Wang Q; He XZ; Haddad PR; Hilder EF J Chromatogr A; 2013 Nov; 1317():148-54. PubMed ID: 24011724 [TBL] [Abstract][Full Text] [Related]
26. Streamlining process characterization efforts using the high throughput ambr® crossflow system for ultrafiltration and diafiltration processing of monoclonal antibodies. Fernandez-Cerezo L; Benner SW; Pollard JM Biotechnol Prog; 2021 May; 37(3):e3118. PubMed ID: 33369289 [TBL] [Abstract][Full Text] [Related]
27. Introduction and clearance of beta-glucan in the downstream processing of monoclonal antibodies. Kluters S; Steinhauser K; Pfänder R; Studts J Biotechnol Prog; 2021 Jul; 37(4):e3149. PubMed ID: 33743183 [TBL] [Abstract][Full Text] [Related]
28. Quality by design: impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody. Awotwe-Otoo D; Agarabi C; Wu GK; Casey E; Read E; Lute S; Brorson KA; Khan MA; Shah RB Int J Pharm; 2012 Nov; 438(1-2):167-75. PubMed ID: 22944306 [TBL] [Abstract][Full Text] [Related]
29. Impact of Stainless Steel Exposure on the Oxidation of Polysorbate 80 in Histidine Placebo and Active Monoclonal Antibody Formulation. Gopalrathnam G; Sharma AN; Dodd SW; Huang L PDA J Pharm Sci Technol; 2018; 72(2):163-175. PubMed ID: 29343621 [TBL] [Abstract][Full Text] [Related]
30. Multistage continuous countercurrent diafiltration for formulation of monoclonal antibodies. Jabra MG; Yehl CJ; Zydney AL Biotechnol Prog; 2019 Jul; 35(4):e2810. PubMed ID: 30950235 [TBL] [Abstract][Full Text] [Related]
31. Electrostatic model for protein adsorption in ion-exchange chromatography and application to monoclonal antibodies, lysozyme and chymotrypsinogen A. Guélat B; Ströhlein G; Lattuada M; Morbidelli M J Chromatogr A; 2010 Aug; 1217(35):5610-21. PubMed ID: 20663509 [TBL] [Abstract][Full Text] [Related]
32. Combination of Zetaprep mass ion-exchange media and high-performance cation-exchange chromatography for the purification of high-purity monoclonal antibodies. Jungbauer A; Unterluggauer F; Steindl F; Rüker F; Katinger H J Chromatogr; 1987 Jun; 397():313-20. PubMed ID: 3654824 [TBL] [Abstract][Full Text] [Related]
33. Optimization of a platform process operating space for a monoclonal antibody susceptible to reversible and irreversible aggregation using a solution stability screening approach. Man A; Luo H; Levitskaya SV; Macapagal N; Newell KJ J Chromatogr A; 2019 Jul; 1597():100-108. PubMed ID: 30922716 [TBL] [Abstract][Full Text] [Related]
34. Effects of Impurities from Sugar Excipient on Filtrate Flux during Ultrafiltration and Diafiltration Process. Lee J; Na J; Baek Y Membranes (Basel); 2021 Oct; 11(10):. PubMed ID: 34677543 [TBL] [Abstract][Full Text] [Related]
35. Process analytical technology for on-line monitoring of quality attributes during single-use ultrafiltration/diafiltration. West JM; Feroz H; Xu X; Puri N; Holstein M; Ghose S; Ding J; Li ZJ Biotechnol Bioeng; 2021 Jun; 118(6):2293-2300. PubMed ID: 33666234 [TBL] [Abstract][Full Text] [Related]
36. Buffer capacity of biologics--from buffer salts to buffering by antibodies. Karow AR; Bahrenburg S; Garidel P Biotechnol Prog; 2013; 29(2):480-92. PubMed ID: 23296746 [TBL] [Abstract][Full Text] [Related]
37. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering. Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466 [TBL] [Abstract][Full Text] [Related]
38. Protein-protein interactions and water activity coefficients can be used to aid a first excipient choice in protein formulations. Schleinitz M; Sadowski G; Brandenbusch C Int J Pharm; 2019 Oct; 569():118608. PubMed ID: 31415881 [TBL] [Abstract][Full Text] [Related]
39. Systematic interpolation method predicts protein chromatographic elution with salt gradients, pH gradients and combined salt/pH gradients. Creasy A; Barker G; Carta G Biotechnol J; 2017 Mar; 12(3):. PubMed ID: 27992113 [TBL] [Abstract][Full Text] [Related]
40. The osmotic pressure of highly concentrated monoclonal antibody solutions: effect of solution conditions. Binabaji E; Rao S; Zydney AL Biotechnol Bioeng; 2014 Mar; 111(3):529-36. PubMed ID: 23996891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]